2024

1. Advances in heart failure management

   Medicina Clinica, Vol. 163, Núm. 1, pp. 32-39

2. Atrial secondary tricuspid regurgitation: Pathophysiology, definition, diagnosis, and treatment

   European Heart Journal, Vol. 45, Núm. 11, pp. 895-911

3. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

   JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

4. Cardiac wasting and cancer

   European Heart Journal

5. Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer Registry

   JACC: Advances, Vol. 3, Núm. 7

6. Characterizing the “iceberg peak” in valvular heart disease: Outcomes and costs of in-hospital procedures in Spain

   REC: CardioClinics

7. Circulating miRNA in functional tricuspid regurgitation. Unveiling novel links to heart failure: A pilot study

   ESC Heart Failure, Vol. 11, Núm. 4, pp. 2272-2286

8. Concomitant Transcatheter Tricuspid Annuloplasty and Edge-to-Edge Repair in Torrential Tricuspid Regurgitation

   JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 99-100

9. Electroporation saves the day again: Pulsed-field ablation for phrenic nerve-sparing in right atrial tachycardia

   Journal of Cardiovascular Electrophysiology

10. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 18-33

11. How to improve patient outcomes following TAVI in 2024? Recent advances

    Kardiologia Polska, Vol. 82, Núm. 7-8, pp. 696-701

12. Is DOAC the preferred oral anticoagulation therapy after TAVI?

    Revista Espanola de Cardiologia

13. Long-term right heart remodeling after transcatheter tricuspid annuloplasty assessed by cardiac tomography

    Journal of Cardiovascular Computed Tomography

14. NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis

    Journal of Hypertension, Vol. 42, Núm. 4, pp. 685-693

15. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials

    European Journal of Heart Failure, Vol. 26, Núm. 7, pp. 1608-1615

16. Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)

    Medicina Clinica

17. Procedural and clinical outcomes of patients undergoing a TAVI in TAVI procedure: Rationale and design of the multicentre, prospective, observational ReTAVI registry

    European Journal of Clinical Investigation, Vol. 54, Núm. 9

18. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

19. Pupil reflex as a marker of activity and prognosis in heart failure: a longitudinal and prospective study

    ESC Heart Failure, Vol. 11, Núm. 4, pp. 1947-1954

20. Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial

    JACC: Heart Failure, Vol. 12, Núm. 4, pp. 695-706